Anticytokine therapy for periodontal diseases: Where are we now?

Periodontal destruction is initiated by bacteria that stimulate host responses leading to excess production of cytokines. Anticytokine therapy for periodontal diseases especially targets proinflammatory cytokines, that is, TNF-α, IL-1, and IL-6, because these are essential for the initiation of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Waykole, Yogesh Prakash, Doiphode, S. S., Rakhewar, P. S., Mhaske, Maya
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847126/
https://www.ncbi.nlm.nih.gov/pubmed/20407652
http://dx.doi.org/10.4103/0972-124X.55837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847126/
https://www.ncbi.nlm.nih.gov/pubmed/20407652
http://dx.doi.org/10.4103/0972-124X.55837

Ejemplares similares